Go to deals
Healthcare | Logistics

The Blood Alliance has merged with OneBlood

July 2015 — The Blood Alliance (TBA) has merged with OneBlood. Financial details have not been disclosed.

The Blood Alliance is a non-profit community bloodcenter that provides blood to more than 30 hospitals and medical facilities in Florida, Georgia, and South Carolina. It provides a safe and adequate blood supply to the regions it serves and is a member of America’s Blood Centers – a national network of independent community blood centers responsible for nearly half of the nation’s blood supply. TBA has been enriching lives since 1942 and is licensed by the FDA and accredited by the AABB.

Based in Orlando, Florida, OneBlood, which was formed as the result of a merger of three blood banks in 2012, is a community blood bank serving the Tampa Bay area, south and southeast Florida, the Orlando metropolitan area and surrounding central Florida counties, parts of southwest Florida, Pensacola and Tallahassee and some parts of southern Georgia and Alabama.

Our role in the transaction

Oaklins' team in Jacksonville acted as intermediary and financial advisor to The Blood Alliance in this transaction.

Parties

Talk to the deal team

Doug Kravet

Principal
Jacksonville, United States
Oaklins Heritage

Don Wiggins

Principal
Jacksonville, United States
Oaklins Heritage

Related deals

Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more
Life & Mobility has attracted investor Bolster Investment Partners
Private Equity | Healthcare

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.  

Learn more
Synergia and Bolster have secured acquisition financing for Life & Mobility
Private Equity | Healthcare

Synergia and Bolster have secured acquisition financing for Life & Mobility

Synergia Capital Partners and Bolster Investment Partners have partnered with Life & Mobility, a leading Dutch developer and manufacturer of premium mobility and rehabilitation solutions. The partnership marks an important next step in Life & Mobility’s growth trajectory, focused on further international expansion, continued product innovation and strengthening its leading market position.

Learn more